Global Oligonucleotide Synthesis Market 2024-2028

Description

List of Tables

The oligonucleotide synthesis market is forecasted to grow by USD 3374.04 mn during 2023-2028, accelerating at a CAGR of 13.54% during the forecast period. The report on the oligonucleotide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing shift toward RNA-based therapeutics, increasing use of oligonucleotides as therapeutic and diagnostic tools, and technological innovations in oligonucleotide synthesis.

Technavio's oligonucleotide synthesis market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	13.32%
CAGR	13.54%
Incremental Value	$3374.04mn

By Application

PCR primers
PCR assays and panels
DNA microarrays
Fluorescence in situ hybridization
Sequencing and others

By End-user

Pharmaceutical and biotechnology companies
Research and academic institutes
Diagnostic laboratories
Hospitals

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the integration of ai and automation in oligonucleotide synthesis as one of the prime reasons driving the oligonucleotide synthesis market growth during the next few years. Also, increasing research and funding for oligonucleotide synthesis and rise in demand for low-cost and high-throughput oligonucleotide synthesis will lead to sizable demand in the market.

The report on the oligonucleotide synthesis market covers the following areas:

Oligonucleotide synthesis market sizing
Oligonucleotide synthesis market forecast
Oligonucleotide synthesis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oligonucleotide synthesis market vendors that include Agilent Technologies Inc., Ajinomoto Bio Pharma. , Alnylam Pharmaceuticals Inc., Amgen Inc., Ansa Biotechnologies, Bio Synthesis Inc, Biogen Inc., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., Kaneka Corp., LGC Science Group Holdings Ltd., Merck KGaA, Mettler Toledo International Inc., QIAGEN NV, Sarepta Therapeutics Inc., Synbio Technologies, Syngene International Ltd., and Thermo Fisher Scientific Inc.. Also, the oligonucleotide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR74336

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global oligonucleotide synthesis market 2018 - 2022
4.2 Application Segment Analysis 2018 - 2022
4.3 End-user Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Application

6.1 Market segments
6.2 Comparison by Application
6.3 PCR primers - Market size and forecast 2023-2028
6.4 PCR assays and panels - Market size and forecast 2023-2028
6.5 DNA microarrays - Market size and forecast 2023-2028
6.6 Fluorescence in situ hybridization - Market size and forecast 2023-2028
6.7 Sequencing and others - Market size and forecast 2023-2028
6.8 Market opportunity by Application

7 Market Segmentation by End-user

7.1 Market segments
7.2 Comparison by End-user
7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
7.4 Research and academic institutes - Market size and forecast 2023-2028
7.5 Diagnostic laboratories - Market size and forecast 2023-2028
7.6 Hospitals - Market size and forecast 2023-2028
7.7 Market opportunity by End-user

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 China - Market size and forecast 2023-2028
9.9 Germany - Market size and forecast 2023-2028
9.10 Canada - Market size and forecast 2023-2028
9.11 Japan - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Agilent Technologies Inc.
12.4 Ansa Biotechnologies
12.5 Biogen Inc.
12.6 Biotage AB
12.7 Danaher Corp.
12.8 General Electric Co.
12.9 Kaneka Corp.
12.10 LGC Science Group Holdings Ltd.
12.11 Merck KGaA
12.12 Mettler Toledo International Inc.
12.13 QIAGEN NV
12.14 Sarepta Therapeutics Inc.
12.15 Synbio Technologies
12.16 Syngene International Ltd.
12.17 Thermo Fisher Scientific Inc.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations